For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | Participants who were administered the placebo during the first 2-week treatment period. | 0 | None | 0 | 11 | 3 | 11 | View |
| TJ-68 | Participants who were administered TJ-68 during the first 2-week treatment period. | 0 | None | 2 | 11 | 5 | 11 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Facial rash | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Stomachache | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Elevated blood pressure | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Flu-like symptoms | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Joint pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Scleral erythema | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| COVID-19 | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fall | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Rash acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Urinary frequency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Abdominal bloating | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |